RxDoctor Payments Data

Robert Dibenedetto, MD

Obstetrics & Gynecology · Alexandria, LANPI 1588084610

Payments from drug & device makers

$454in general payments, 2019–2025

Across 16 payments — averaging $28.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Avanos Medical$152
  • Coopersurgical, Inc.$111
  • Hologic Sales And Service, LLC$41
  • AbbVie$38
  • Smith+Nephew$24
  • Johnson & Johnson$24
  • plus $63 from 4 others

What the payments were for

  • Food & beverage$454100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$454 in reported general payments places this provider in the 30th percentile of 608 obstetrics & gynecology providers in Louisiana.

See all obstetrics & gynecology providers in Louisiana

Medicare billing

Part B allowed, 2024
$17,179
Medicare patients
122
Services billed
187

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
GemtesaVibegron42$23,846
MyrbetriqMirabegron49$23,320
PremarinEstrogens, Conjugated46$19,792
Estradiol91$5,817
Tranexamic Acid11$566
Oxybutynin Chloride ErOxybutynin Chloride30$357
ValacyclovirValacyclovir Hcl11$346
Norethindrone Acetate12$315
Medroxyprogesterone Acetate28$249
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst13$197
Clobetasol Propionate15$185
Nystatin11$140
Metronidazole25$138
ConstuloseLactulose11$75
Fluconazole11$71

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerPremarin$17$19,79246 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 30th percentile of 608 obstetrics & gynecology providers in Louisiana.

Other obstetrics & gynecology in Alexandria

See the full list for Louisiana

Where these figures come from

Is this you, or does something look wrong? →